Last update 11 Oct 2025

HTPEP-001

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
HTPEP 001, HTPEP-001
Target
THBS1
Action
antagonists
Mechanism
THBS1 antagonists(Thrombospondin 1 antagonists)
Therapeutic Areas
Respiratory DiseasesOther DiseasesNeoplasms
Active Indication
Progressive fibrotic interstitial lung diseaseIdiopathic Pulmonary FibrosisSolid tumor
Inactive Indication-
Originator Organization
Chengdu Huitai Biomedical Co., Ltd.Chengdu Huitai Biomedical Co., Ltd.
Active Organization
Chengdu Huitai Biomedical Co., Ltd.Chengdu Huitai Biomedical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with HTPEP-001
CTR20241874
/ CompletedPhase 1
一项在健康受试者中评估吸入用HTPEP-001安全、耐受性和药代动力学的随机、双盲、安慰剂对照的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of inhaled HTPEP-001 in healthy subjects
100 Clinical Results associated with HTPEP-001
Login to view more data
100 Translational Medicine associated with HTPEP-001
Login to view more data
100 Patents (Medical) associated with HTPEP-001
Login to view more data
100 Deals associated with HTPEP-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Progressive fibrotic interstitial lung diseasePhase 1
China
Chengdu Huitai Biomedical Co., Ltd.Chengdu Huitai Biomedical Co., Ltd.
08 Jul 2024
Idiopathic Pulmonary FibrosisIND Application
China
Chengdu Huitai Biomedical Co., Ltd.Chengdu Huitai Biomedical Co., Ltd.
30 Jan 2022
Solid tumorPreclinical
China
Chengdu Huitai Biomedical Co., Ltd.Chengdu Huitai Biomedical Co., Ltd.
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free